|
|
||||||||

* Departamento de Inmunología, Facultad de Medicina, Hospital Universitario "Reina Sofía," Universidad de Córdoba, Córdoba, Spain, and
Unidad de Inmunología, Facultad de Medicina, Universidad de Granada, Granada, Spain
Correspondence: Dr. Manuel Santamaría, Servicio de Inmunología, Hospital Universitario Reina Sofía, Avenida Menendez Pidal s/n, E-14004 Córdoba, Spain. E-mail: msantamaria{at}uco.es
We investigated the ability of human peripheral CD4+ cells
to express CD94 and NKG2 molecules as a consequence of
CD3-mediated activation. Using highly purified peripheral
CD4+ T cells, we found expression of both CD94 and NKG2A 15
days after CD3-mediated stimulation of cells. We also determined by
reverse transcriptase-PCR that all gene members of NKG2 familynamely,
NKG2A, -C, -D, and -Eare sequentially expressed on CD4+
cells. We found that this expression is tightly regulated by cytokines,
and we identified transforming growth factor-ß1 and interleukin-10 as
the main factors that, on CD3-dependent stimulation, positively
contribute to the expression of CD94 and NKG2A on CD4+
cells. We also investigated the functional role of NKG2A and found that
coligation of CD3 and NKG2A by specific monoclonal antibodies results
in significant inhibition of interferon
and tumor necrosis factor
production by stimulated CD4+ cells. The presence and
function of these receptors on CD4+ lymphocytes support a
more general role for NKG2 molecules, whose functions were originally
thought to be confined to cytotoxic cells, in the immune system.
Key Words: C-type lectin receptors cytokine regulation TNF-
IFN-
This article has been cited by other articles:
![]() |
B. T. Wilhelm, J.-R. Landry, F. Takei, and D. L. Mager Transcriptional Control of Murine CD94 Gene: Differential Usage of Dual Promoters by Lymphoid Cell Types J. Immunol., October 15, 2003; 171(8): 4219 - 4226. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |